The financing is expected to accelerate commercialization of the Zenflow Spring System for benign prostatic hyperplasia ...
GlobalData on MSN
Zenflow raises $52m for BPH implant and inks US distribution pact with Cook Medical
Zenflow’s Spring implant, designed to treat the symptoms of benign prostatic hyperplasia (BPH), secured FDA clearance in December 2025.
Zenflow, Inc., developer of the Zenflow Spring® System, announced the close of an oversubscribed $52 million Series D financing round. The round was led by Cook Medical, with participation from new ...
Cook Medical led the financing round, and signed up to exclusively distribute Zenflow's minimally invasive Spring implant.
Cook Medical has become Zenflow’s U.S. distributor in a urology device market targeted by Boston Scientific, Olympus and ...
Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center have identified a distinct type of prostate cell ...
Hosted on MSN
Prodeon Medical’s BPH implant gains FDA clearance
The US Food and Drug Administration (FDA) has cleared Prodeon Medical’s implantable technology for treating lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). The ...
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device for benign prostatic hyperplasia (BPH). This latest funding ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results